1. Medtech Insight
  2. >>Leadership

Filling The Device Sector's Diversity Gap: MedTech Color Builds Support

 
• By David Filmore

MedTech Color is focused on enhancing diversity in the device and diagnostics space and increasing thought leadership opportunities for people of color in the industry. The organization held a launch event at this year's MedTech Conference in Philadelphia, where Medtech Insight caught up with founder Kwame Ulmer.

Kawme Ulmer Interview Screenshot
Kwame Ulmer talks about strategies for improving diversity in medtech • Source: Ferdous Al-Faruque

The device sector has fallen behind other industries in addressing the lack of ethnic diversity among its executives and entrepreneurs, and directed efforts are needed to address the gaps. That's the message from Kwame Ulmer and others who officially launched a new group last week called MedTech Color to help tackle the issue.

Medtech Insight caught up with Ulmer, a device industry consultant and former US FDA official, at the breakfast launch event for the group Sept. 26 in Philadelphia, where AdvaMed's MedTech Conference was taking place. As an industry, "We are a bit behind," Ulmer, a device industry consultant and former US FDA official, told Medtech Insight

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Subsense Develops Nonsurgical, Nanoparticle-Based Brain-Computer Interface For Neurological Disorders

 
• By Marion Webb

Neurotechnology start-up Subsense came out of stealth with $17m in seed funding to develop a nonsurgical, nanoparticle-based brain-computer interface. Medtech Insight spoke with the firm’s new neurotech lead Cyril Eleftheriou about the technology and its potentially wide applications for treating Parkinson’s, epilepsy, inner speech decoding, and more.

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By Elizabeth Orr

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.

Execs On The Move: 14-18 April 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

LSX Roundup: Startups Elypta, QuantiLight And Plexaa Debut New Tech

 
• By Natasha Barrow

Back-to-back meetings at LSX? No time to attend the innovator showcase? Here is what you might have missed from medtech innovators at the LSX World Congress Europe on 29 April.

More from Medtech Insight